HSBC Holdings’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
HSBC Holdings's PBYI Position: Q3 2025 in Review
HSBC Holdings sold out of Puma Biotechnology (PBYI) in Q3 2025, closing a stake of 19,751 shares — an estimated $66.6K sold.
HSBC Holdings first reported a position in PBYI in Q2 2015 and held it in 14 quarters. The position peaked at $2.25M in Q2 2018. 132 funds tracked by Wall St. Rank hold PBYI as of Q3 2025.
- HSBC Holdings reported no remaining Puma Biotechnology position as of Q3 2025 after selling out during the quarter.
- HSBC Holdings sold 19,751 Puma Biotechnology shares in Q3 2025, an estimated $66.6K.
- HSBC Holdings first reported a position in Puma Biotechnology in Q2 2015 and held it in 14 quarters.
- HSBC Holdings's Puma Biotechnology position peaked at $2.25M in Q2 2018.
- 132 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2025.
Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.